[Clinical outcome of CAG regimen in 26 children with aucte myeloid leukemia]

Zhonghua Xue Ye Xue Za Zhi. 2019 Jul 14;40(7):594-596. doi: 10.3760/cma.j.issn.0253-2727.2017.07.011.
[Article in Chinese]
No abstract available

MeSH terms

  • Aclarubicin / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Child
  • Cytarabine / therapeutic use
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Remission Induction
  • Treatment Outcome

Substances

  • Cytarabine
  • Granulocyte Colony-Stimulating Factor
  • Aclarubicin

Supplementary concepts

  • CAG protocol

Grants and funding

基金项目：国家自然科学基金（81470339）